Nova Eye Medical (AU:EYE) has released an update.
Nova Eye Medical Limited has announced changes in the securities interests of its director, Thomas Anthony Spurling. The director’s direct and indirect holdings have increased following the lapse of 700,000 options. This update may influence investor sentiments as it reflects a shift in insider holdings.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.